過(guò)表達(dá)CCR7的脂肪間充質(zhì)干細(xì)胞對(duì)大鼠異體復(fù)合組織移植早期免疫調(diào)節(jié)作用的研究
發(fā)布時(shí)間：2019-05-18 14:14
【摘要】：研究背景和目的同種異體復(fù)合組織移植對(duì)特殊部位或大面積組織缺損的修復(fù)效果較理想,但為避免術(shù)后急性排斥反應(yīng),患者需長(zhǎng)期大劑量服用免疫抑制劑,產(chǎn)生諸多副作用,阻礙其臨床開展。間充質(zhì)干細(xì)胞(mesenchymal stem cells, MSCs)以其免疫調(diào)節(jié)作用成為同種異體復(fù)合組織移植免疫領(lǐng)域的研究熱點(diǎn)。MSCs通過(guò)旁分泌細(xì)胞因子和細(xì)胞直接接觸作用調(diào)節(jié)多種免疫細(xì)胞的活化和增殖,并有研究指出脂肪來(lái)源的MSCs免疫調(diào)節(jié)作用優(yōu)于其他組織來(lái)源的MSCs。同種異體復(fù)合組織移植急性排斥反應(yīng)由T淋巴細(xì)胞介導(dǎo),次級(jí)淋巴器官(secondary lymphoid organs, SLOs),包括脾和淋巴結(jié)等,是T細(xì)胞定居和啟動(dòng)免疫反應(yīng)的場(chǎng)所。然而,靜脈注射的MSCs在體內(nèi)各組織器官中隨機(jī)分布,體內(nèi)對(duì)T細(xì)胞的免疫調(diào)節(jié)作用不如體外理想。研究表明,利用含CCR7基因的慢病毒轉(zhuǎn)染可使MSCs過(guò)表達(dá)CC趨化因子受體-7 (CC chemokinereceptor7,CCR7)并有效歸巢于次級(jí)淋巴器官,有助于減輕T細(xì)胞介導(dǎo)的移植物抗宿主反應(yīng)。因此,本課題旨在探索人脂肪間充質(zhì)干細(xì)胞(human adipose-drived stem cells, hASCs)是否能過(guò)表達(dá)大鼠的CCR7并能有效歸巢大鼠的次級(jí)淋巴器官,從而減輕大鼠同種異體復(fù)合組織移植后的急性排斥反應(yīng),為臨床治療同種異體復(fù)合組織移植早期的免疫排斥反應(yīng)提供新的策略。方法1.細(xì)胞準(zhǔn)備。1)分離培養(yǎng)鑒定hASCs,RT-PCR和流式方法檢測(cè)炎性細(xì)胞因子刺激前后的hASCsCCR7水平;2)用含有大鼠CCR7-GFP基因及其對(duì)照GFP基因的慢病毒轉(zhuǎn)染 hASCs,使其成為 rCCR7-GFP-hASCs(C-A)和 GFP-hASCs(G-A),RT-PCR方法檢測(cè)轉(zhuǎn)染后細(xì)胞內(nèi)基因元件WPRE水平及CCR7水平,流式方法檢測(cè)膜CCR7表達(dá)水平;3)比較病毒轉(zhuǎn)染前后細(xì)胞的表面標(biāo)志物(流式檢測(cè)),分化能力(誘導(dǎo)成骨、成脂、成軟骨分化)及細(xì)胞增殖能力(CCK-8法)。2.體外趨化能力和體內(nèi)歸巢能力檢驗(yàn)。1)利用transwell檢測(cè)C-A和G-A向趨化因子CCL21的定向遷移能力;2)流式方法檢測(cè)比較靜脈注射C-A和G-A的大鼠脾和淋巴結(jié)中GFP陽(yáng)性細(xì)胞所占比例;3)脾和淋巴結(jié)的冰凍切片免疫熒光染色檢測(cè)細(xì)胞是否歸巢次級(jí)淋巴器官及其與T細(xì)胞的空間分布關(guān)系。3.體內(nèi)外C-A對(duì)大鼠T細(xì)胞的免疫調(diào)節(jié)作用的檢測(cè)。1)體外,將hASCs、C-A和G-A各以兩個(gè)濃度梯度與混合淋巴反應(yīng)共培養(yǎng),流式檢測(cè)T細(xì)胞分化情況(CD4+的輔助性T細(xì)胞所占比例及其中Th1、Th2、Th17、Treg所占比例)以及上清中的細(xì)胞因子IFN-γ、IL-2、IL-6、IL-17、IL-4、IL-10的含量;2)大鼠尾靜脈注射細(xì)胞24h后,行同種異體下腹部皮瓣游離移植,術(shù)后連續(xù)觀察皮瓣外觀變化,比較術(shù)后第3d、7d、14d皮瓣病理表現(xiàn),檢測(cè)脾和淋巴結(jié)中T細(xì)胞分化情況及血漿中細(xì)胞因子IFN-γ、IL-2、IL-6、IL-17、IL-4、IL-10的含量(方法同上)。結(jié)果1、hASCs成功分離,且炎性細(xì)胞因子刺激前后均檢測(cè)不到CCR7表達(dá);含CCR7-GFP基因的慢病毒及其對(duì)照GFP病毒轉(zhuǎn)染均使hASCs表達(dá)綠色熒光蛋白;C-A和G-A胞內(nèi)WPRE水平明顯高于未轉(zhuǎn)染的hASCs細(xì)胞(P0.001),且C-A高表達(dá)大鼠CCR7, G-A不表達(dá)CCR7;轉(zhuǎn)染前后的細(xì)胞形態(tài)、表面標(biāo)志物、分化能力和增殖能力無(wú)明顯差異。2、體外,C-A向趨化因子遷移量較G-A顯著增多(P0.001);大鼠體內(nèi),C-A注射組脾和淋巴結(jié)中GFP陽(yáng)性細(xì)胞所占比例顯著高于G-A注射組(P0.01);脾和淋巴結(jié)冰凍切片免疫熒光染色中,C-A或G-A自發(fā)綠色熒光,T細(xì)胞被標(biāo)記紅色熒光,C-A注射組脾和淋巴結(jié)中綠色熒光細(xì)胞明顯多于G-A注射組,且綠色熒光細(xì)胞聚集于發(fā)紅色熒光的細(xì)胞周圍。3、①體外混合淋巴反應(yīng)結(jié)果:hASCs組細(xì)胞增殖的集落少于對(duì)照組,CD4+細(xì)胞比例及Th1/ Th2比值顯著低于對(duì)照組(P0.01),Treg/Th17比值高于對(duì)照組(P0.05);hASCs組上清中促炎細(xì)胞因子IFN-y、IL-2、IL-6、IL-17含量低于對(duì)照組(P0.05),而抗炎細(xì)胞因子IL-4、IL-10高于對(duì)照組(P0.05);不同濃度hASCs比較,差別有統(tǒng)計(jì)學(xué)意義。②皮瓣觀測(cè)結(jié)果:C-A組移植物存活時(shí)間較G-A組和單純移植組長(zhǎng)(P0.01);外觀出現(xiàn)急性排斥反應(yīng)的最初征象較其余兩組晚;同一取材時(shí)間點(diǎn),C-A組的病理表現(xiàn)最輕。③體內(nèi)指標(biāo)檢測(cè)結(jié)果:C-A組脾和淋巴結(jié)中Th1/Th2比值高峰出現(xiàn)較晚,之后迅速下降,Treg/Th17比值持續(xù)升高;當(dāng)其余兩組血漿IFN-γ、IL-2、IL-4、IL-10較高時(shí),C-A組相應(yīng)指標(biāo)較低。之后C-A組IFN-γ、IL-2先升高又迅速降低,IL-4、IL-10持續(xù)升高,IL-6、IL-17緩慢上升又下降。結(jié)論CCR7-hASCs能有效歸巢次級(jí)淋巴器官并聚集于T細(xì)胞分布區(qū),通過(guò)調(diào)節(jié)Th1/Th2和Treg/Th17平衡,減輕大鼠異體復(fù)合組織移植早期的急性排斥反應(yīng),為應(yīng)用hASCs調(diào)節(jié)同種異體復(fù)合組織移植的免疫反應(yīng)提供一定的依據(jù)。
[Abstract]:In order to avoid the postoperative acute rejection, the patients need to take long-term and long-term administration of the immunosuppressive agent, which can prevent the clinical development. Mesenchymal stem cells (MSCs) play an important role in the study of the immune regulation of the allogenic compound tissue. MSCs can regulate the activation and proliferation of a plurality of immune cells by direct contact of the paracrine cytokines and the cells, and the research indicates that the immunomodulatory effect of the fat-derived MSCs is superior to that of other tissue-derived MSCs. The acute rejection of the allogenic compound tissue is mediated by T-lymphocytes, secondary lymphoid organs (SLOs), including the spleen and the lymph nodes, and are the sites for the T-cell settlement and the initiation of the immune response. However, the injected MSCs are randomly distributed in various organs of the body, and the immunoregulation effect of the in vivo on T cells is not as ideal as in vitro. Studies have shown that the use of a lentiviral transfection containing a CCR7 gene can make it possible for MSCs to overexpress the CC chemokine receptor-7 (CC chemotactic factor 7, CCR7) and to effectively nest with the secondary lymphoid organs, contributing to the reduction of T cell-mediated graft-versus-host reactions. Therefore, the purpose of this study is to explore whether human adipose-derived stem cells (hASs) can express the CCR7 of the rat and can be used for the effective homing of the secondary lymphoid organs of the rat, so as to reduce the acute rejection after the transplantation of the allogenic compound tissue of the rat. And provides a new strategy for the clinical treatment of the early immune rejection reaction of the allogenic compound tissue transplantation. Method 1. Cell preparation.1) Isolation and identification of hASCs, RT-PCR and flow methods for the detection of the level of hASCCCR7 before and after the inflammatory cytokine stimulation;2) transfecting hASCs with lentiviruses containing the rat CCR7-GFP gene and its control GFP gene to be rCCR7-GFP-hASs (C-A) and GFP-hASCs (G-A), in that RT-PCR method, the WPRE level and the CCR7 level of the gene element in the transfected cell are detected, the expression level of the membrane CCR7 is detected by the flow method, Chondrogenic differentiation) and cell proliferation ability (CCK-8 method). in vitro chemotactic ability and in vivo homing capacity test.1) the directional migration ability of C-A and G-A to the chemokine CCL21 was detected by transwell;2) the proportion of GFP positive cells in the spleen and the lymph nodes of the rats compared with the intravenous C-A and G-A was detected by the flow method; 3) The immunofluorescence staining of the frozen sections of the spleen and the lymph nodes was used to detect whether the cells were in the secondary lymphoid organs of the nest and their spatial distribution with the T cells. 1) In vitro, hASCs, C-A and G-A were co-cultured with mixed lymph reaction with two concentration gradients, and the proportion of T-cell differentiation (CD4 + helper T-cells and the ratio of Th1, Th2, Th17, The ratio of Treg and the content of IL-2, IL-6, IL-17, IL-4 and IL-10 in the supernatant and the content of IL-6, IL-17, IL-4 and IL-10 in the supernatant of the rat were observed. The changes of T cell in the spleen and lymph nodes and the levels of IL-2, IL-6, IL-17, IL-4 and IL-10 in the plasma were detected by the 14-d skin flap. Results 1. The expression of CCR7 was not detected before and after the successful separation of hASCs, and the expression of CCR7 was not detected before and after the stimulation of the inflammatory cytokines. The expression of the green fluorescent protein was made by the transfection of the lentivirus containing the CCR7-GFP gene and the control GFP virus. The level of the WPRE in the C-A and G-A cells was significantly higher than that of the untransfected hASs cells (P0.001). The expression of CCR7 and G-A in C-A showed no significant difference in the cell morphology, surface marker, differentiation ability and proliferation ability before and after transfection. In vitro, the migration of C-A to chemokines increased significantly (P 0.001); in rats, The proportion of GFP positive cells in the spleen and lymph nodes of the C-A injection group was significantly higher than that of the G-A group (P0.01); in the immunofluorescence staining of the frozen sections of the spleen and the lymph nodes, the C-A or G-A spontaneous green fluorescence and the T cells were labeled with red fluorescence, In that C-A group, the green fluorescent cells in the spleen and lymph nodes were significantly more than that of the G-A injection group, and the green fluorescent cells were clustered around the cells emitting red fluorescence. The ratio of CD4 + cells and the ratio of Th1/ Th2 was significantly lower than that in the control group (P0.01), and the ratio of Treg/ Th17 was higher than that of the control group (P0.05). The content of the pro-inflammatory cytokines, IFN-y, IL-2, IL-6 and IL-17 in the group of hASs was lower than that of the control group (P0.05), while the anti-inflammatory cytokine IL-4 and IL-10 were higher than that in the control group (P0.05). The difference of hASCs in different concentrations was statistically significant. The results showed that the survival time of C-A group was less than that of G-A group and the group of pure transplantation (P0.01). The first sign of acute rejection in appearance was later than that of the other two groups. At the same time point, the pathological behavior of C-A group was the lightest. The results showed that the ratio of Th1/ Th2 in the spleen and lymph nodes of the C-A group was late and then decreased rapidly, and the ratio of Treg/ Th17 continued to increase; when the other two groups of plasma IFN-1, IL-2, IL-4 and IL-10 were higher, the corresponding index of C-A group was lower. The increase of IL-4, IL-10 and IL-6 and IL-17 in group C-A and IL-6, IL-6 and IL-17 increased and decreased. Conclusion CCR7-hASs can be used for the effective homing of the secondary lymphoid organs and aggregation in the T cell distribution area. By adjusting the balance of Th1/ Th2 and Treg/ Th17, the acute rejection in the early stage of the transplantation of the allogenic compound tissue of the rat is reduced, and a certain basis is provided for the application of hASs to regulate the immune response of the allogenic compound tissue transplantation.
【學(xué)位授予單位】：中國(guó)人民解放軍醫(yī)學(xué)院
【學(xué)位級(jí)別】：博士
【學(xué)位授予年份】：2017
【分類號(hào)】：R622
本文編號(hào)：2480073
[Abstract]:In order to avoid the postoperative acute rejection, the patients need to take long-term and long-term administration of the immunosuppressive agent, which can prevent the clinical development. Mesenchymal stem cells (MSCs) play an important role in the study of the immune regulation of the allogenic compound tissue. MSCs can regulate the activation and proliferation of a plurality of immune cells by direct contact of the paracrine cytokines and the cells, and the research indicates that the immunomodulatory effect of the fat-derived MSCs is superior to that of other tissue-derived MSCs. The acute rejection of the allogenic compound tissue is mediated by T-lymphocytes, secondary lymphoid organs (SLOs), including the spleen and the lymph nodes, and are the sites for the T-cell settlement and the initiation of the immune response. However, the injected MSCs are randomly distributed in various organs of the body, and the immunoregulation effect of the in vivo on T cells is not as ideal as in vitro. Studies have shown that the use of a lentiviral transfection containing a CCR7 gene can make it possible for MSCs to overexpress the CC chemokine receptor-7 (CC chemotactic factor 7, CCR7) and to effectively nest with the secondary lymphoid organs, contributing to the reduction of T cell-mediated graft-versus-host reactions. Therefore, the purpose of this study is to explore whether human adipose-derived stem cells (hASs) can express the CCR7 of the rat and can be used for the effective homing of the secondary lymphoid organs of the rat, so as to reduce the acute rejection after the transplantation of the allogenic compound tissue of the rat. And provides a new strategy for the clinical treatment of the early immune rejection reaction of the allogenic compound tissue transplantation. Method 1. Cell preparation.1) Isolation and identification of hASCs, RT-PCR and flow methods for the detection of the level of hASCCCR7 before and after the inflammatory cytokine stimulation;2) transfecting hASCs with lentiviruses containing the rat CCR7-GFP gene and its control GFP gene to be rCCR7-GFP-hASs (C-A) and GFP-hASCs (G-A), in that RT-PCR method, the WPRE level and the CCR7 level of the gene element in the transfected cell are detected, the expression level of the membrane CCR7 is detected by the flow method, Chondrogenic differentiation) and cell proliferation ability (CCK-8 method). in vitro chemotactic ability and in vivo homing capacity test.1) the directional migration ability of C-A and G-A to the chemokine CCL21 was detected by transwell;2) the proportion of GFP positive cells in the spleen and the lymph nodes of the rats compared with the intravenous C-A and G-A was detected by the flow method; 3) The immunofluorescence staining of the frozen sections of the spleen and the lymph nodes was used to detect whether the cells were in the secondary lymphoid organs of the nest and their spatial distribution with the T cells. 1) In vitro, hASCs, C-A and G-A were co-cultured with mixed lymph reaction with two concentration gradients, and the proportion of T-cell differentiation (CD4 + helper T-cells and the ratio of Th1, Th2, Th17, The ratio of Treg and the content of IL-2, IL-6, IL-17, IL-4 and IL-10 in the supernatant and the content of IL-6, IL-17, IL-4 and IL-10 in the supernatant of the rat were observed. The changes of T cell in the spleen and lymph nodes and the levels of IL-2, IL-6, IL-17, IL-4 and IL-10 in the plasma were detected by the 14-d skin flap. Results 1. The expression of CCR7 was not detected before and after the successful separation of hASCs, and the expression of CCR7 was not detected before and after the stimulation of the inflammatory cytokines. The expression of the green fluorescent protein was made by the transfection of the lentivirus containing the CCR7-GFP gene and the control GFP virus. The level of the WPRE in the C-A and G-A cells was significantly higher than that of the untransfected hASs cells (P0.001). The expression of CCR7 and G-A in C-A showed no significant difference in the cell morphology, surface marker, differentiation ability and proliferation ability before and after transfection. In vitro, the migration of C-A to chemokines increased significantly (P 0.001); in rats, The proportion of GFP positive cells in the spleen and lymph nodes of the C-A injection group was significantly higher than that of the G-A group (P0.01); in the immunofluorescence staining of the frozen sections of the spleen and the lymph nodes, the C-A or G-A spontaneous green fluorescence and the T cells were labeled with red fluorescence, In that C-A group, the green fluorescent cells in the spleen and lymph nodes were significantly more than that of the G-A injection group, and the green fluorescent cells were clustered around the cells emitting red fluorescence. The ratio of CD4 + cells and the ratio of Th1/ Th2 was significantly lower than that in the control group (P0.01), and the ratio of Treg/ Th17 was higher than that of the control group (P0.05). The content of the pro-inflammatory cytokines, IFN-y, IL-2, IL-6 and IL-17 in the group of hASs was lower than that of the control group (P0.05), while the anti-inflammatory cytokine IL-4 and IL-10 were higher than that in the control group (P0.05). The difference of hASCs in different concentrations was statistically significant. The results showed that the survival time of C-A group was less than that of G-A group and the group of pure transplantation (P0.01). The first sign of acute rejection in appearance was later than that of the other two groups. At the same time point, the pathological behavior of C-A group was the lightest. The results showed that the ratio of Th1/ Th2 in the spleen and lymph nodes of the C-A group was late and then decreased rapidly, and the ratio of Treg/ Th17 continued to increase; when the other two groups of plasma IFN-1, IL-2, IL-4 and IL-10 were higher, the corresponding index of C-A group was lower. The increase of IL-4, IL-10 and IL-6 and IL-17 in group C-A and IL-6, IL-6 and IL-17 increased and decreased. Conclusion CCR7-hASs can be used for the effective homing of the secondary lymphoid organs and aggregation in the T cell distribution area. By adjusting the balance of Th1/ Th2 and Treg/ Th17, the acute rejection in the early stage of the transplantation of the allogenic compound tissue of the rat is reduced, and a certain basis is provided for the application of hASs to regulate the immune response of the allogenic compound tissue transplantation.
【學(xué)位授予單位】：中國(guó)人民解放軍醫(yī)學(xué)院
【學(xué)位級(jí)別】：博士
【學(xué)位授予年份】：2017
【分類號(hào)】：R622
【參考文獻(xiàn)】
相關(guān)期刊論文 前8條
1 馬恬;韓巖;;間充質(zhì)干細(xì)胞在同種異體復(fù)合組織移植中的免疫調(diào)節(jié)作用[J];中華醫(yī)學(xué)雜志;2016年14期
2 楊曉勇;姚慶春;胡小鵬;王瑋;尹航;任亮;劉航;張小東;;雷帕霉素體外預(yù)處理樹突細(xì)胞調(diào)節(jié)Treg/Th17細(xì)胞誘導(dǎo)小鼠移植免疫耐受[J];中華醫(yī)學(xué)雜志;2015年30期
3 張穎杰;郭希民;錢志勇;劉志佳;高鈺;周林;李紅;韓巖;;過(guò)表達(dá)CC趨化因子受體7的C3H10 T1/2細(xì)胞具有更強(qiáng)的免疫抑制效應(yīng)[J];細(xì)胞與分子免疫學(xué)雜志;2015年07期
4 歐陽(yáng)容蘭;張棟梁;李小毅;張勇;黃書潤(rùn);;趨化因子受體CCR7的免疫學(xué)功能研究進(jìn)展[J];解放軍醫(yī)藥雜志;2015年04期
5 馬錫慧;肖漓;石炳毅;;間充質(zhì)干細(xì)胞免疫抑制作用及其在移植免疫中應(yīng)用的研究進(jìn)展[J];中華細(xì)胞與干細(xì)胞雜志(電子版);2015年01期
6 楊靖;柴家科;劉玲英;;間充質(zhì)干細(xì)胞對(duì)燒傷創(chuàng)面免疫調(diào)控作用的研究進(jìn)展[J];中華損傷與修復(fù)雜志(電子版);2014年06期
7 韓夫;王耀軍;王耘川;賈艷慧;楊龍龍;賈文斌;方小兵;白曉智;胡大海;;吲哚胺2,3-雙加氧酶基因修飾BMSCs在大鼠同種異體復(fù)合組織移植免疫排斥反應(yīng)中的作用研究[J];中國(guó)修復(fù)重建外科雜志;2014年06期
8 齊丙迪;孟寶璽;楊陽(yáng);劉蓓;李翅翅;夏煒;郭樹忠;張晨;;第三方骨髓間充質(zhì)干細(xì)胞誘導(dǎo)同種異體移植受體免疫耐受機(jī)制的研究[J];中華整形外科雜志;2011年03期
，本文編號(hào)：2480073
本文鏈接：http://sikaile.net/yixuelunwen/waikelunwen/2480073.html
最近更新
教材專著
